Welcome to our dedicated page for Octave Specialty Group SEC filings (Ticker: OSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Overseas Shipholding Group’s Jones Act tankers keep U.S. energy moving, but understanding how charter rates, vessel utilization, and environmental rules affect earnings means sifting through dense SEC paperwork. If you have ever typed “Overseas Shipholding Group SEC filings explained simply” or wondered why a single ballast-water footnote can alter cash flow, you are in the right place.
Stock Titan combines real-time EDGAR feeds with AI-powered summaries to decode every document—from an Overseas Shipholding Group annual report 10-K simplified to the latest Overseas Shipholding Group quarterly earnings report 10-Q filing. Our platform highlights fleet age tables, Jones Act renewal schedules, and segment revenue so you can spot trends without scrolling hundreds of pages. Need alerts on board-room moves? Get Overseas Shipholding Group Form 4 insider transactions real-time and trace “Overseas Shipholding Group executive stock transactions Form 4” in seconds. Material event announced? The “Overseas Shipholding Group 8-K material events explained” card shows whether a vessel sale or charter cancellation drives the headline.
Use cases include:
- Monitoring “Overseas Shipholding Group insider trading Form 4 transactions” before dividend decisions
- Comparing time-charter equivalent rates across quarters using AI-tagged metrics
- Reviewing “Overseas Shipholding Group proxy statement executive compensation” to gauge incentive alignment
- Scanning “Overseas Shipholding Group earnings report filing analysis” for bunker-fuel cost impacts
- “Understanding Overseas Shipholding Group SEC documents with AI” to support credit models
No more manual downloads or maritime jargon marathons—just clear explanations, comprehensive coverage of every form type, and instant answers to natural questions like “Where can I find Overseas Shipholding Group’s 10-K risk factors?” All filings, all the time, already distilled for action.
Octave Specialty Group, Inc. filed an 8-K describing its completed acquisition of ArmadaCorp Capital, LLC for total consideration of approximately $250.0 million in cash, funded in part by $120.0 million of borrowings made at closing. The company explains that this transaction, referred to as the ArmadaCorp Transaction, closed on October 31, 2025.
The filing primarily provides historical and pro forma financial information related to the acquired business. It includes unaudited consolidated financial statements of ArmadaCorp as of and for the nine months ended September 30, 2025 and 2024, and audited financial statements for the years ended December 31, 2024 and 2023. It also provides unaudited pro forma combined financial information for Octave Specialty Group, including a combined balance sheet as of September 30, 2025 and combined statements of operations for the year ended December 31, 2024 and the nine months ended September 30, 2025, so readers can see how the acquisition might have affected the company’s results.
Octave Specialty Group Inc. reported a new equity award to one of its directors. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a right to receive one share of Octave Specialty Group common stock. The RSUs were recorded at an exercise price of $0 and are held as direct beneficial ownership, bringing the director’s total derivative securities beneficially owned to 8,650.
The RSUs granted on January 1, 2026 are scheduled to fully vest on January 1, 2027. Once vested, they convert into shares of common stock on the vesting date or when the director leaves the Board, unless the director has elected to defer settlement.
Octave Specialty Group Inc. director reports new equity award. A board member of Octave Specialty Group Inc. recorded a grant of 4,524 restricted stock units (RSUs) effective January 1, 2026. Each RSU represents a contingent right to receive one share of the company’s common stock.
The RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into shares of common stock on the earlier of the vesting date or the date the director leaves the company’s Board of Directors, subject to any deferral election by the reporting person. Following this transaction, the filing shows 8,650 derivative securities beneficially owned on a direct basis.
Octave Specialty Group Inc. director reported receiving restricted stock units that could convert into common shares. On January 1, 2026, the reporting person was granted 4,524 restricted stock units (RSUs), each tied to one share of Octave Specialty Group Inc. common stock. The RSUs are listed with a price of $0 and are shown as a direct holding.
The filing states that these RSUs will vest on January 1, 2027. Once vested, they will settle into shares of common stock on the earlier of the vesting date or the date the director resigns from, or otherwise ceases to be a member of, the company’s Board of Directors, unless the director elects to defer settlement. After this transaction, the filing shows 8,650 derivative securities beneficially owned.
Octave Specialty Group Inc. reported an equity award to a board member. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a contingent right to one share of Octave Specialty Group common stock. These RSUs are scheduled to vest on January 1, 2027, and any vested RSUs will convert into common shares on the earlier of the vesting date or when the director leaves the Board, unless the director elects to defer settlement. After this grant, the director beneficially owns 8,650 derivative securities in the form of RSUs.
Octave Specialty Group Inc. reported an equity award to a board member in the form of restricted stock units. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a contingent right to receive one share of Octave Specialty Group common stock. These RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into common shares on the earlier of the vesting date or the date the director leaves the company’s Board of Directors, unless the director elects to defer settlement. After this grant, the reporting person held a total of 8,650 derivative securities related to the company’s stock in direct ownership.
Octave Specialty Group Inc. reported an equity grant to a board member. A director received 4,524 restricted stock units (RSUs) of Octave Specialty Group Inc. common stock on January 1, 2026. Each RSU represents a right to receive one share of common stock and was granted at a price of $0 per unit. The RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into common shares on the earlier of the vesting date or the date the director ceases to serve on the company’s Board of Directors, unless the director elects to defer settlement. Following this grant, the reporting person holds 8,650 derivative securities directly.
Octave Specialty Group Inc. director and Chief Executive Officer reported buying additional company stock. On 01/02/2026, a Form 4 shows an open-market purchase of 12,000 shares of common stock at a price of $7.59 per share, coded as an acquisition transaction. After this trade, the reporting person beneficially owns 1,033,777 shares of Octave Specialty Group Inc. common stock in direct ownership. The filing reflects a single, straightforward insider purchase with no derivative securities activity disclosed.
Octave Specialty Group Inc. disclosed that one of its officers, serving as Senior Managing Director and General Counsel, filed an initial insider ownership report effective 12/11/2025.
The report states that this reporting person currently has no securities beneficially owned, and it was signed by attorney-in-fact William J. White on 12/17/2025.